Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.
Data Scientist, Cardiff, UK.
J Gen Intern Med. 2022 Jun;37(8):1943-1952. doi: 10.1007/s11606-021-07242-1. Epub 2022 Mar 22.
After mild COVID-19, some outpatients experience persistent symptoms. However, data are scarce and prospective studies are urgently needed.
To characterize the post-COVID-19 syndrome after mild COVID-19 and identify predictors.
Outpatients with symptoms suggestive of COVID-19 with (1) PCR-confirmed COVID-19 (COVID-positive) or (2) SARS-CoV-2 negative PCR (COVID-negative).
Monocentric cohort study with prospective phone interview between more than 3 months to 10 months after initial visit to the emergency department and outpatient clinics.
Data of the initial visits were extracted from the electronic medical file. Predefined persistent symptoms were assessed through a structured phone interview. Associations between long-term symptoms and PCR results, as well as predictors of persistent symptoms among COVID-positive, were evaluated by multivariate logistic regression adjusted for age, gender, smoking, comorbidities, and timing of the survey.
The study population consisted of 418 COVID-positive and 89 COVID-negative patients, mostly young adults (median age of 41 versus 36 years in COVID-positive and COVID-negative, respectively; p = 0.020) and healthcare workers (67% versus 82%; p = 0.006). Median time between the initial visit and the phone survey was 150 days in COVID-positive and 242 days in COVID-negative patients. Persistent symptoms were reported by 223 (53%) COVID-positive and 33 (37%) COVID-negative patients (p = 0.006) and proportions were stable among the periods of the phone interviews. Overall, 21% COVID-positive and 15% COVID-negative patients (p = 0.182) attended care for this purpose. Four surveyed symptoms were independently associated with COVID-19: fatigue (adjusted odds ratio 2.14, 95% CI 1.04-4.41), smell/taste disorder (26.5, 3.46-202), dyspnea (2.81, 1.10-7.16), and memory impairment (5.71, 1.53-21.3). Among COVID-positive, female gender (1.67, 1.09-2.56) and overweight/obesity (1.67, 1.10-2.56) were predictors of persistent symptoms.
More than half of COVID-positive outpatients report persistent symptoms up to 10 months after a mild disease. Only 4 of 14 symptoms were associated with COVID-19 status. The symptoms and predictors of the post-COVID-19 syndrome need further characterization as this condition places a significant burden on society.
轻度 COVID-19 后,一些门诊患者会出现持续症状。然而,目前数据有限,迫切需要开展前瞻性研究。
描述轻度 COVID-19 后 COVID-19 后综合征的特征,并确定其预测因素。
有 COVID-19 症状且(1)PCR 确诊 COVID-19(COVID-19 阳性)或(2)SARS-CoV-2 PCR 阴性(COVID-19 阴性)的门诊患者。
前瞻性队列研究,在急诊科和门诊就诊后 3 至 10 个月进行电话随访。
从电子病历中提取初始就诊数据。通过结构化电话访谈评估长期存在的症状。通过多变量逻辑回归评估长期症状与 PCR 结果之间的关联,以及 COVID-19 阳性患者中持续性症状的预测因素,该回归调整了年龄、性别、吸烟、合并症和调查时间。
研究人群包括 418 名 COVID-19 阳性患者和 89 名 COVID-19 阴性患者,主要为年轻成年人(中位年龄分别为 41 岁和 36 岁;COVID-19 阳性患者和 COVID-19 阴性患者的比例分别为 67%和 82%;p=0.006)和医务人员(分别为 67%和 82%;p=0.006)。COVID-19 阳性患者和 COVID-19 阴性患者从初始就诊到电话调查的中位时间分别为 150 天和 242 天。223 名(53%)COVID-19 阳性患者和 33 名(37%)COVID-19 阴性患者报告存在持续性症状(p=0.006),且在电话访谈期间的比例保持稳定。总体而言,21%的 COVID-19 阳性患者和 15%的 COVID-19 阴性患者(p=0.182)因该症状就诊。四个调查症状与 COVID-19 独立相关:疲劳(调整后的优势比 2.14,95%置信区间 1.04-4.41)、嗅觉/味觉障碍(26.5,3.46-202)、呼吸困难(2.81,1.10-7.16)和记忆障碍(5.71,1.53-21.3)。在 COVID-19 阳性患者中,女性(1.67,1.09-2.56)和超重/肥胖(1.67,1.09-2.56)是持续性症状的预测因素。
超过一半的 COVID-19 门诊患者在轻度疾病后 10 个月仍会出现持续症状。只有 14 种症状中的 4 种与 COVID-19 状态有关。COVID-19 后综合征的症状和预测因素需要进一步描述,因为这种情况会给社会带来很大的负担。